Philippe Guerci: HIT after Cardiac Surgery – Are We Using the Right Tools?
Philippe Guerci, Professor at CHRU de Nancy, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiothoracic and Vascular Anesthesia, adding:
“New publication – HIT after cardiac surgery: are we using the right tools?
Work led by Thomas Klein, bringing together a highly talented team of hematobiologists (Philippe Savard, Toussaint Hacquard Marie, Emmanuel de Maistre, Thomas Lecompte), clinicians (Sandrine Grosjean, Guillaume Soyer) and methodologists-biostatisticians (Cedric Baumann, Amandine Luc, Elodie Jeanbert) across two expert centers.
Congratulations to all.
This bicentric study (Nancy 🇫🇷 and Dijon 🇫🇷) provides one of the most robust comparative evaluations to date of clinical scores for heparin-induced thrombocytopenia (HIT) in the challenging context of cardiac surgery with CPB.
Key findings:
- No clear winner among the 4 major HIT scores (4Ts, HEP, CPB, GFHT)
- All scores show excellent rule-out performance (NPV nearly 94–97%)
- Limited positive predictive value – caution against overdiagnosis
- Identification of a typical biphasic platelet pattern (early drop and delayed nadir nearly day 10) as a strong clinical signal
- The HEP score trends toward best overall performance, but without statistical superiority
Clinical message:
- In post-cardiac surgery patients, HIT scores are rule-out tools, not rule-in tools
- Diagnostic strategies must remain multimodal, combining clinical expertise with advanced functional assays
- This work highlights the strength of close collaboration between anesthesiologists, intensivists, and hematobiologists, essential to tackle complex perioperative coagulation disorders.
A great example of how bicenter collaboration enhances external validity and clinical relevance.”
Title: Evaluating Four HIT Prediction Scores After Cardiac Surgery With Cardiopulmonary Bypass: A Comparative Study
Authors: Guillaume Soyer, Philippe Savard, Philippe Guerci, Marie Toussaint Hacquard, Elodie Jeanbert, Amandine Luc, Cédric Baumann, Sandrine Grosjean, Emmanuel de Maistre, Thomas Lecompte, Thomas Klein

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy